pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
JNS-101
Friedreich Ataxia
$JUNS
JUPITER NEUROSCIENCES, INC.
0
catalysts
Phase 2
JWATM-204
Hepatocellular Carcinoma
Eureka Therapeutics Inc
0
catalysts
Phase 2
JadiCell ARDS
Acute Respiratory Distress Syndrome
Breathe Biologics Inc
0
catalysts
Phase 2
Jankistomig
Solid Tumor
← prev
page 16 of 50
next →
131
Pain
89
Neurology
1
Ottimo Pharma Ltd
0
catalysts
Phase 2
KB-707
Metastatic Melanoma
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KB-801
Neurotrophic Keratitis
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
KBLP-001
Plaque Psoriasis (Psoriasis Vulgaris)
KoBioLabs Inc
0
catalysts
Phase 2
KITE-363
Diffuse Large B-Cell Lymphoma
Kite Pharma Inc
0
catalysts
Phase 2
KITE-753
Diffuse Large B-Cell Lymphoma
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 2
KK-8123
X-Linked Hypophosphatemic Rickets
Kyowa Kirin Co Ltd
0
catalysts
Phase 2
KL4 Surfactant
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Windtree Therapeutics Inc
0
catalysts
Phase 2
KLS-2031
Neuropathic Pain (Neuralgia)
Kolon Life Science Inc
0
catalysts
Phase 2
KM-819
Parkinson's Disease
Fascinate Therapeutics Inc
0
catalysts
Phase 2
KP-1077
serdexmethylphenidate
Idiopathic Hypersomnia (IH)
Sodium-dependent dopamine transporter
Sodium-dependent noradrenaline transporter
$ZVRA
ZEVRA THERAPEUTICS, INC.
0
catalysts
Phase 2
KSL-W
Dental Plaque
US Army Medical Research & Materiel Command
0
catalysts
Phase 2
KSQ-001
Head And Neck Squamous Cell Carcinoma (HNSC)
KSQ Therapeutics Inc
0
catalysts
Phase 2
KSQ-004
Acral Lentiginous Melanoma
KSQ Therapeutics Inc
0
catalysts
Phase 2
KT-621
Eosinophilic Asthma
$KYMR
Kymera Therapeutics, Inc.
0
catalysts
Phase 2
KTP-001
Lumbar Hernia/Bleichner's Hernia
Teijin Pharma Ltd
0
catalysts
Phase 2
KUS-121
Retinal Artery Occlusion
Kyoto Drug Discovery & Development Co Ltd
0
catalysts
Phase 2
Ketamir-2
Chemotherapy Induced Peripheral Neuropathy
Miralogx LLC
0
catalysts
Phase 2
L-Citrulline
Sickle Cell Disease With Vaso-Occlusive Crisis
Asklepion Pharmaceuticals LLC
0
catalysts
Phase 2
LACTIN-V
Bacterial Vaginosis
Osel Inc
0
catalysts
Phase 2
LASN-01
Graves' Ophthalmopathy
Lassen Therapeutics 1 Inc
0
catalysts
Phase 2
LAT-010
Breast Cancer
Latticon Antibody Therapeutics Inc
0
catalysts
Phase 2
LB-100
Myelodysplastic Syndrome (Preleukemia)
Serine/threonine-protein phosphatase 5
Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
$LIXT
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
0
catalysts
Phase 2
LB-2102
Neuroendocrine Carcinoma
$NVS
NOVARTIS AG
0
catalysts
Phase 2
LB-P8
Primary Sclerosing Cholangitis
LISCure Biosciences Inc
0
catalysts
Phase 2
LBPEC-01
Escherichia coli Infections
Locus Biosciences Inc
0
catalysts
Phase 2
LCB-71
Diffuse Large B-Cell Lymphoma
CStone Pharmaceuticals Co Ltd
0
catalysts
